These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3877192)

  • 1. [Increased production of interleukin-1 by macrophage from the patients with chronic liver disease and its implication for liver fibrosis].
    Koda K; Niitsu Y; Bunya M; Ito N; Sasagawa Y; Owada M; Morita K; Kohgo Y; Urushizaki I
    Nihon Shokakibyo Gakkai Zasshi; 1985 Jun; 82(6):1527-32. PubMed ID: 3877192
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interleukin-1 and liver cirrhosis].
    Ramadori G
    Z Gastroenterol; 1988 Aug; 26(8):437-8. PubMed ID: 3265242
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytotoxic activity of the lymphocytes in patients with chronic hepatitis and liver cirrhosis].
    Mokhov VM; Lisok TP; Petrov AL
    Ter Arkh; 1983; 55(2):43-5. PubMed ID: 6601859
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibodies against hepatitis B virus in chronic non-alcoholic HBsAg-negative hepatopathies].
    Moreira Vicente VF; Simón Marco MA; Pascasio Acevedo JM; Ruiz del Arbol Olmos L; Larraona Moreno JL; González Martín JA; Aguilera Musso D; Barcena Marugan R; Bueno Vallejo R
    Med Clin (Barc); 1984 Mar; 82(12):522-30. PubMed ID: 6738151
    [No Abstract]   [Full Text] [Related]  

  • 5. Interleukin 1 activity in culture supernatant of lipopolysaccharide-stimulated monocytes from patients with chronic liver disease.
    Sakamoto S; Koga S; Ibayashi H
    Hepatogastroenterology; 1984 Dec; 31(6):248-53. PubMed ID: 6335123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of the leukocyte migration inhibition reaction to human liver lipoprotein in children with chronic hepatitis and liver cirrhosis].
    Imbaeva AA; Chistova LV; Ivanov VG; Titovskĭ VI
    Pediatriia; 1986 Nov; (11):39-41. PubMed ID: 3808830
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanisms of chronicity of liver diseases].
    Loginov AS
    Klin Med (Mosk); 1991 Dec; 69(12):7-10. PubMed ID: 1787685
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
    Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C
    Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional and metabolic activity of lymphocytes in chronic hepatitis, liver cirrhosis and chronic cholecystitis].
    Nikolaev AI; Mamutov ZhI; Fazylov AV
    Ter Arkh; 1989; 61(9):109-12. PubMed ID: 2595568
    [No Abstract]   [Full Text] [Related]  

  • 10. [The significance of immunological indicators in the diagnosis of chronic diseases of the liver].
    Iakhontova OI; Karashurova LL; Starkova SA
    Vrach Delo; 1988 Apr; (4):39-41. PubMed ID: 3261058
    [No Abstract]   [Full Text] [Related]  

  • 11. [Functional activity of natural killer cells in patients with chronic liver diseases].
    Dzhalalova VA; Madzhidov AV; Drozd TN; Pogromov AP
    Ter Arkh; 1985; 57(2):74-7. PubMed ID: 4002143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of circulating immune complexes in chronic hepatopathies].
    Delsignore R; Baroni MC; Mineo F; Conversi E; Campana G; Butturini U
    G Clin Med; 1984; 65(9-10):389-94. PubMed ID: 6530118
    [No Abstract]   [Full Text] [Related]  

  • 13. Proliferation and immunoglobulin synthesis of peripheral blood mononuclear cells from patients with chronic liver disease stimulated by Staphylococcus aureus Cowan 1 and interleukin 2.
    Kakumu S; Fuji A; Ohtani Y; Murase K; Hirofuji H; Tahara H
    Gastroenterol Jpn; 1987 Jun; 22(3):337-43. PubMed ID: 3114035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 1 alpha production by peripheral blood monocytes from patients with chronic liver disease and effect of sera on interleukin 1 alpha production.
    Kakumu S; Tahara H; Fuji A; Yoshioka K
    J Clin Lab Immunol; 1988 Jul; 26(3):113-9. PubMed ID: 3148031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte stimulation and chronic liver disease.
    Tobias H; Safran AP; Schaffner F
    Lancet; 1967 Jan; 1(7483):193-5. PubMed ID: 4163129
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection.
    Anastassakos C; Alexander GJ; Wolstencroft RA; Avery JA; Portmann BC; Panayi GS; Dumonde DC; Eddleston AL; Williams R
    Gastroenterology; 1988 Apr; 94(4):999-1005. PubMed ID: 3257934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in HBV-specific DNA polymerase activity in relation to the severity of HBsAg positive chronic liver disease].
    Kawakami H; Kikkawa M; Matsuura T; Kawamoto H; Watanabe Y; Ikemoto Y; Suemori S; Kaziyama G; Aimitsu S; Takeno H
    Nihon Shokakibyo Gakkai Zasshi; 1985 Feb; 82(2):239-46. PubMed ID: 3999443
    [No Abstract]   [Full Text] [Related]  

  • 18. [The mediators of inflammation and chronic hepatitis].
    García Buey L; García Monzón C; Moreno Otero R
    Gastroenterol Hepatol; 1995 Jan; 18(1):42-54. PubMed ID: 7621270
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevalence of the surface antigen of the hepatitis type B virus (HBsAg) in chronic hepatic disease].
    Ocaña Andrade E; Valverde Castañeda N; Garrido Palma J; Carrillo Cambero JL
    Rev Gastroenterol Mex; 1985; 50(1):19-22. PubMed ID: 4089439
    [No Abstract]   [Full Text] [Related]  

  • 20. [T and B lymphocytes in hepatic diseases].
    Collazo L; Sotto A
    Acta Gastroenterol Latinoam; 1985; 15(1):7-12. PubMed ID: 3879074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.